Celgene ROA 2006-2018 | CELG

Current and historical return on assets (ROA) values for Celgene (CELG) over the last 10 years.
Celgene Annual ROA - Return on Assets
2017 9.75
2016 7.12
2015 5.94
2014 11.53
2013 10.84
2012 12.41
2011 13.17
2010 8.65
2009 14.41
2008 -34.50
2007 6.27
2006 2.52
2005 5.06
Celgene Quarterly ROA - Return on Assets
Q2 2018 3.13
Q1 2018 2.45
Q4 2017 -0.27
Q3 2017 3.11
Q2 2017 3.63
Q1 2017 3.23
Q4 2016 1.53
Q3 2016 0.64
Q2 2016 2.25
Q1 2016 3.09
Q4 2015 2.08
Q3 2015 -0.13
Q2 2015 2.01
Q1 2015 4.11
Q4 2014 3.54
Q3 2014 3.10
Q2 2014 3.83
Q1 2014 2.20
Q4 2013 1.60
Q3 2013 2.73
Q2 2013 4.00
Q1 2013 3.36
Q4 2012 2.24
Q3 2012 3.65
Q2 2012 3.54
Q1 2012 3.88
Q4 2011 4.10
Q3 2011 3.82
Q2 2011 2.78
Q1 2011 2.59
Q4 2010 2.06
Q3 2010 4.29
Q2 2010 2.52
Q1 2010 3.92
Q4 2009 4.72
Q3 2009 4.27
Q2 2009 3.01
Q1 2009 3.54
Q4 2008 -3.36
Q3 2008 3.14
Q2 2008 2.90
Q1 2008 -41.96
Q4 2007 2.09
Q3 2007 1.15
Q2 2007 1.74
Q1 2007 1.99
Q4 2006 0.84
Q3 2006 1.34
Q2 2006 0.70
Q1 2006 1.21
Q4 2005 0.31
Q3 2005 0.06
Q2 2005 0.94
Q1 2005 4.28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $64.154B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.843B 14.44
Gilead Sciences (GILD) United States $99.468B 11.04
Biogen (BIIB) United States $69.095B 14.65
Illumina (ILMN) United States $48.547B 60.82
Vertex Pharmaceuticals (VRTX) United States $44.677B 101.64
Regeneron Pharmaceuticals (REGN) United States $39.849B 22.41
Alexion Pharmaceuticals (ALXN) United States $26.493B 19.91
BioMarin Pharmaceutical (BMRN) United States $18.018B 0.00
Incyte (INCY) United States $13.698B 460.29
Seattle Genetics (SGEN) United States $11.644B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.803B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.361B 60.17
BeiGene (BGNE) Cayman Islands $8.886B 0.00
QIAGEN (QGEN) Netherlands $8.737B 28.57
Sarepta Therapeutics (SRPT) United States $8.606B 0.00
Bluebird Bio (BLUE) United States $8.568B 0.00
Alkermes (ALKS) Ireland $6.839B 0.00
Bio-Techne Corp (TECH) United States $6.714B 45.12
Exact Sciences (EXAS) United States $6.129B 0.00
Exelixis (EXEL) United States $6.080B 19.81
Galapagos (GLPG) Belgium $5.547B 0.00
Ligand Pharmaceuticals (LGND) United States $5.115B 45.31
Immunomedics (IMMU) United States $3.951B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.861B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.824B 0.00
Horizon Pharma Public (HZNP) Ireland $3.491B 19.76
Intercept Pharmaceuticals (ICPT) United States $3.356B 0.00
Array BioPharma (ARRY) United States $3.117B 0.00
China Biologic Products (CBPO) China $3.093B 20.43
Blueprint Medicines (BPMC) United States $3.022B 0.00
Myriad Genetics (MYGN) United States $3.013B 36.04
Akcea Therapeutics (AKCA) United States $2.994B 0.00
Amicus Therapeutics (FOLD) United States $2.903B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.887B 0.00
Medicines (MDCO) United States $2.843B 0.00
Ascendis Pharma (ASND) Denmark $2.807B 0.00
Emergent Biosolutions (EBS) United States $2.753B 21.92
Halozyme Therapeutics (HALO) United States $2.452B 32.67
Global Blood Therapeutics (GBT) United States $2.402B 0.00
MyoKardia (MYOK) United States $2.399B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.242B 0.00
Spark Therapeutics (ONCE) United States $2.195B 0.00
Acceleron Pharma (XLRN) United States $2.185B 0.00
REGENXBIO (RGNX) United States $2.178B 34.21
Repligen (RGEN) United States $2.158B 72.46
Cambrex (CBM) United States $2.042B 16.37
Momenta Pharmaceuticals (MNTA) United States $2.034B 0.00
AnaptysBio (ANAB) United States $2.006B 0.00
Genomic Health (GHDX) United States $1.945B 108.50
G1 THERAPEUTICS (GTHX) United States $1.894B 0.00
Mirati Therapeutics (MRTX) United States $1.893B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.865B 0.00
Rubius Therapeutics (RUBY) United States $1.837B 0.00
Clovis Oncology (CLVS) United States $1.831B 0.00
Arena Pharmaceuticals (ARNA) United States $1.811B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.768B 0.00
Atara Biotherapeutics (ATRA) United States $1.728B 0.00
Insmed (INSM) United States $1.712B 0.00
Puma Biotechnology (PBYI) United States $1.700B 0.00
Reata Pharmaceuticals (RETA) United States $1.681B 0.00
Aimmune Therapeutics (AIMT) United States $1.660B 0.00
Sangamo Therapeutics (SGMO) United States $1.591B 0.00
Allakos (ALLK) United States $1.575B 0.00
Myovant Sciences (MYOV) United Kingdom $1.454B 0.00
IMMURON LTD (IMRN) Australia $1.452B 0.00
Denali Therapeutics (DNLI) United States $1.430B 0.00
Innoviva (INVA) United States $1.414B 9.08
Editas Medicine (EDIT) United States $1.413B 0.00
Lion Biotechnologies (IOVA) United States $1.400B 0.00
Solid Biosciences (SLDB) United States $1.351B 0.00
Audentes Therapeutics (BOLD) United States $1.345B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.340B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.314B 0.00
UniQure (QURE) Netherlands $1.311B 0.00
BIOHAVEN PHARM (BHVN) United States $1.308B 0.00
WAVE Life Sciences (WVE) Singapore $1.290B 0.00
Coherus BioSciences (CHRS) United States $1.289B 0.00
Acorda Therapeutics (ACOR) United States $1.277B 26.63
Intellia Therapeutics (NTLA) United States $1.195B 0.00
Cellectis (CLLS) France $1.171B 0.00
Athenex (ATNX) United States $1.169B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.164B 0.00
Intra-Cellular Therapies (ITCI) United States $1.161B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.134B 2165.00
Zai Lab Unsponsored ADR (ZLAB) China $1.112B 0.00
CytomX Therapeutics (CTMX) United States $1.094B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.082B 0.00
Retrophin (RTRX) United States $1.048B 0.00
DBV Technologies (DBVT) France $1.048B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.043B 0.00
Apellis Pharmaceuticals (APLS) United States $1.038B 0.00
NeoGenomics (NEO) United States $1.020B 178.57
AVROBIO (AVRO) United States $0.981B 0.00
Revance Therapeutics (RVNC) United States $0.979B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.884B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.864B 0.00
Amarin (AMRN) Ireland $0.836B 0.00
Dynavax Technologies (DVAX) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.827B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.773B 0.00
Cara Therapeutics (CARA) United States $0.768B 0.00
Heska (HSKA) United States $0.734B 63.16
NuCana Sponsored ADR (NCNA) United Kingdom $0.732B 0.00
InflaRx (IFRX) Germany $0.727B 0.00
Kura Oncology (KURA) United States $0.725B 0.00
Aptinyx (APTX) United States $0.714B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.699B 0.00
Epizyme (EPZM) United States $0.697B 0.00
Geron (GERN) United States $0.692B 0.00
ANI Pharmaceuticals (ANIP) United States $0.673B 13.36
UNITY Biotechnology (UBX) $0.666B 0.00
Abeona Therapeutics (ABEO) United States $0.646B 0.00
UROGEN PHARMA (URGN) Israel $0.645B 0.00
Sorrento Therapeutics (SRNE) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.628B 0.00
AC Immune SA (ACIU) Switzerland $0.618B 0.00
Fate Therapeutics (FATE) United States $0.614B 0.00
Eidos Therapeutics (EIDX) United States $0.605B 0.00
Anika Therapeutics (ANIK) United States $0.604B 25.40
Verastem (VSTM) United States $0.599B 0.00
Prothena (PRTA) Ireland $0.597B 0.00
Mesoblast (MESO) Australia $0.593B 0.00
Vericel (VCEL) United States $0.551B 0.00
Novavax (NVAX) United States $0.547B 0.00
ObsEva SA (OBSV) Switzerland $0.547B 0.00
BeyondSpring (BYSI) United States $0.529B 0.00
Arcus Biosciences (RCUS) United States $0.526B 0.00
Arbutus Biopharma (ABUS) Canada $0.524B 0.00
Replimune (REPL) United States $0.521B 0.00
Kindred Biosciences (KIN) United States $0.507B 0.00
Senesco Technologies (ELOX) United States $0.501B 0.00
Five Prime Therapeutics (FPRX) United States $0.501B 0.00
MiMedx (MDXG) United States $0.476B 20.43
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.472B 0.00
Unum Therapeutics (UMRX) United States $0.469B 0.00
Zymeworks (ZYME) Canada $0.453B 0.00
Stemline Therapeutics (STML) United States $0.453B 0.00
Aduro Biotech (ADRO) United States $0.447B 0.00
Magenta Therapeutics (MGTA) United States $0.428B 0.00
Merus (MRUS) Netherlands $0.426B 0.00
Zealand Pharma (ZEAL) Denmark $0.423B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.420B 0.00
Evelo Biosciences (EVLO) United States $0.417B 0.00
Syros Pharmaceuticals (SYRS) United States $0.411B 0.00
Inovio Pharmaceuticals (INO) United States $0.408B 0.00
GTx (GTXI) United States $0.403B 0.00
Vital Therapies (VTL) United States $0.398B 0.00
MediciNova (MNOV) United States $0.395B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.395B 0.00
Sinovac Biotech (SVA) China $0.391B 0.00
Cytokineticsorporated (CYTK) United States $0.382B 0.00
Albireo Pharma (ALBO) United States $0.373B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.370B 0.00
Scholar Rock Holding (SRRK) United States $0.363B 0.00
RA PHARMCTL INC (RARX) United States $0.352B 0.00
PDL BioPharma (PDLI) United States $0.348B 4.88
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Adverum Biotechnologies (ADVM) United States $0.329B 0.00
Seres Therapeutics (MCRB) United States $0.324B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.320B 0.00
Kezar Life Sciences (KZR) United States $0.319B 0.00
ResTORbio (TORC) United States $0.317B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.317B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.312B 0.00
Kala Pharmaceuticals (KALA) United States $0.310B 0.00
Selecta Biosciences (SELB) United States $0.308B 0.00
Osiris Therapeutics (OSIR) United States $0.307B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.307B 0.00
Mersana Therapeutics (MRSN) United States $0.295B 0.00
Celyad SA (CYAD) Belgium $0.291B 0.00
Cohbar (CWBR) United States $0.290B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.290B 0.00
Athersys (ATHX) United States $0.285B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.285B 0.00
Strongbridge Biopharma (SBBP) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.274B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.273B 0.00
Kadmon Holdings (KDMN) United States $0.268B 0.00
Constellation Pharmaceuticals (CNST) United States $0.266B 0.00
Celcuity (CELC) United States $0.253B 0.00
Axovant Sciences (AXON) United Kingdom $0.253B 0.00
NantKwest (NK) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.249B 0.00
Clearside Biomedical (CLSD) United States $0.243B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.240B 0.00
MeiraGTx Holdings (MGTX) United States $0.238B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Allena Pharmaceuticals (ALNA) United States $0.224B 0.00
Protagonist Therapeutics (PTGX) United States $0.221B 0.00
Kamada (KMDA) Israel $0.209B 16.25
Aeglea BioTherapeutics (AGLE) United States $0.209B 0.00
Agenus (AGEN) United States $0.205B 0.00
Spero Therapeutics (SPRO) United States $0.205B 0.00
Liquidia Technologies (LQDA) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
Enzo Biochem (ENZ) United States $0.195B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.182B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
TOCAGEN INC (TOCA) United States $0.181B 0.00
MannKind (MNKD) United States $0.181B 0.00
Signal Genetics (MGEN) United States $0.180B 0.00
Mustang Bio (MBIO) United States $0.174B 0.00
BioDelivery Sciences (BDSI) United States $0.171B 0.00
Idera Pharmaceuticals (IDRA) United States $0.170B 0.00
Cue Biopharma (CUE) United States $0.167B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.167B 0.00
Krystal Biotech (KRYS) United States $0.166B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.164B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.159B 0.00
Compugen (CGEN) Israel $0.156B 0.00
XOMA (XOMA) United States $0.155B 16.31
OVID THERAPEUTC (OVID) United States $0.152B 0.00
Cerecor (CERC) United States $0.151B 18.58
XBiotech (XBIT) United States $0.149B 0.00
BioXcel Therapeutics (BTAI) United States $0.145B 0.00
Monster Digital (INNT) United States $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.139B 0.00
Intec Pharma (NTEC) Israel $0.130B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
Anavex Life Sciences (AVXL) United States $0.124B 0.00
Trevena (TRVN) United States $0.124B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.120B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.120B 0.00
PSivida (EYPT) United States $0.119B 0.00
Provention Bio (PRVB) United States $0.119B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
NewLink Genetics (NLNK) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.111B 0.00
Aptevo Therapeutics (APVO) United States $0.109B 0.00
Leap Therapeutics (LPTX) United States $0.106B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.102B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.101B 0.00
Orgenesis (ORGS) United States $0.101B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.093B 0.00
Ophthotech (OPHT) United States $0.088B 0.57
Proteostasis Therapeutics (PTI) United States $0.088B 0.00
Eleven Biotherapeutics (SESN) United States $0.087B 0.00
ScPharmaceuticals (SCPH) United States $0.085B 0.00
Alcobra (ARCT) Israel $0.085B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.085B 0.00
Sophiris Bio (SPHS) United States $0.083B 0.00
Tapimmune (TPIV) United States $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.081B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
OncoSec Medical (ONCS) United States $0.079B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Evogene (EVGN) Israel $0.073B 0.00
Prima BioMed (IMMP) Australia $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Histogenics (HSGX) United States $0.070B 0.00
VIVUS (VVUS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.064B 0.00
Novelion Therapeutics (NVLN) Canada $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Eyenovia (EYEN) United States $0.055B 0.00
Neothetics (EVFM) United States $0.055B 0.00
Curis (CRIS) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Celsion (CLSN) United States $0.048B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Proteon Therapeutics (PRTO) United States $0.041B 0.00
GENPREX INC (GNPX) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
TRACON Pharmaceuticals (TCON) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
CytRx (CYTR) United States $0.038B 0.00
Bellerophon Therapeutics (BLPH) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.033B 0.00
Arsanis (ASNS) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 64.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Vical (VICL) United States $0.029B 0.00
Edge Therapeutics (EDGE) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Oncobiologics (ONS) United States $0.027B 0.00
Gemphire Therapeutics (GEMP) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.020B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Neuralstem (CUR) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
RestorGenex (DFFN) United States $0.018B 0.00
Novogen (KZIA) Australia $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.41
Cerulean Pharma (DARE) United States $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Galena Biopharma (SLS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00